[3H]BQ123 [7888]
[3H]BQ123
| SMILES | [3H]C(C(=O)O)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C(C)C)NC(=O)[C@@H]2CCCN2C1=O |
| InChIKey | VYCMAAOURFJIHD-HCGDBENESA-N |
| Sequence | DPVLW |
| HELM | PEPTIDE1{[*C(=O)[C@H](CC(=O)O)N* |$_R2;;;;;;;;;_R1$|].P.[dV].L.[dW]}$PEPTIDE1,PEPTIDE1,5:R2-1:R1$$$ |
Chemical Properties
| Hydrogen bond acceptors | 6 |
| Hydrogen bond donors | 6 |
| Rotatable bonds | 7 |
| Log P | 0.831 |
| Molecular weight (Da) | 612.3 |
| Stereochemistry info | unspecified |
| Radioactive | 3H |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
[3H]BQ123
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0